CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- 4 Planned sale Chief Patient Officer sold 80,000 shares at $6.12 ($489,680)
- 4 Open-market sale Chief Business Officer sold 5,417 shares at $5.93 ($32,132)
- 4 Open-market sale Chief Patient Officer sold 6,261 shares at $5.93 ($37,138)
- 4 Open-market sale Chief Financial Officer sold 7,037 shares at $5.93 ($41,741)
- 4 Open-market sale President & CEO sold 45,687 shares at $5.93 ($271,002)
- 4 Open-market sale See Remarks sold 5,841 shares at $5.93 ($34,647)
- 4 Open-market sale Chief Commercial Officer sold 15,308 shares at $5.93 ($90,802)
- 4 Grant or award Director acquired 41,551 shares (grant or award)
- 4 Grant or award Director acquired 63,019 shares (grant or award)
- 4 Grant or award Director acquired 15,235 shares (grant or award)
- 4 Grant or award Director acquired 72,714 shares (grant or award)
- 4 Grant or award Director acquired 41,551 shares (grant or award)
- 4 Grant or award Director acquired 41,551 shares (grant or award)
- 4 Grant or award Director acquired 60,941 shares (grant or award)
- 4 Open-market buy Director bought 200,000 shares at $3.63 ($725,880)
- 4 Open-market buy Director bought 200,000 shares at $3.69 ($737,260)
- 4 Open-market sale Chief Medical Officer sold 6,421 shares at $4.08 ($26,207)
- 4 Open-market sale Chief Financial Officer sold 7,218 shares at $4.08 ($29,460)
- 4 Open-market sale President & CEO sold 46,817 shares at $4.08 ($191,079)
- 4 Open-market sale See Remarks sold 14,522 shares at $4.08 ($59,270)
Page 4 of 35 · 690 filings